Literature DB >> 1915259

Theoretical and functional analysis of the SIV fusion peptide.

M Horth1, B Lambrecht, M C Khim, F Bex, C Thiriart, J M Ruysschaert, A Burny, R Brasseur.   

Abstract

The fusion domain of simian immunodeficiency virus (SIV) envelope glycoproteins is a hydrophobic region located at the amino-terminal extremity of the transmembrane protein (gp32). Assuming an alpha helical structure for the SIV fusogenic domain of gp32 in a lipid environment, theoretical studies have predicted that the fusion peptide would insert obliquely in the lipid bilayer. This oblique insertion could be an initial step of the fusion process by disorganizing locally the structure of the lipid bilayer. We have tested this hypothesis by selectively mutagenizing the SIV gp160 expressed via a vaccinia virus vector, to alter the theoretical angle of insertion of the fusion peptide. The fusogenic activity of the wild-type and mutant glycoproteins was tested after infection of T4 lymphocytic cell lines by the recombinant vaccinia virus, and measure of syncytia formation. Mutations that modified the oblique orientation reduced the fusogenic activity. In contrast, mutations that conserve the oblique orientation did not alter the fusogenic properties. Our results support the hypothesis that oblique orientation is important for fusogenic activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1915259      PMCID: PMC452983          DOI: 10.1002/j.1460-2075.1991.tb07823.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  27 in total

1.  Phospholipid interactions of synthetic peptides representing the N-terminus of HIV gp41.

Authors:  M Rafalski; J D Lear; W F DeGrado
Journal:  Biochemistry       Date:  1990-08-28       Impact factor: 3.162

2.  A syncytia assay for human immunodeficiency virus type I (HIV-I) envelope protein and its use in studying HIV-I mutations.

Authors:  J M Felser; T Klimkait; J Silver
Journal:  Virology       Date:  1989-06       Impact factor: 3.616

3.  The rapid generation of oligonucleotide-directed mutations at high frequency using phosphorothioate-modified DNA.

Authors:  J W Taylor; J Ott; F Eckstein
Journal:  Nucleic Acids Res       Date:  1985-12-20       Impact factor: 16.971

4.  Hydrophobic binding of the ectodomain of influenza hemagglutinin to membranes occurs through the "fusion peptide".

Authors:  C Harter; P James; T Bächi; G Semenza; J Brunner
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

5.  Membrane fusion by peptide analogues of influenza virus haemagglutinin.

Authors:  S A Wharton; S R Martin; R W Ruigrok; J J Skehel; D C Wiley
Journal:  J Gen Virol       Date:  1988-08       Impact factor: 3.891

6.  Orientation into the lipid bilayer of an asymmetric amphipathic helical peptide located at the N-terminus of viral fusion proteins.

Authors:  R Brasseur; M Vandenbranden; B Cornet; A Burny; J M Ruysschaert
Journal:  Biochim Biophys Acta       Date:  1990-11-16

7.  Secondary structure and orientation of a chemically synthesized mitochondrial signal sequence in phospholipid bilayers.

Authors:  E Goormaghtigh; I Martin; M Vandenbranden; R Brasseur; J M Ruysschaert
Journal:  Biochem Biophys Res Commun       Date:  1989-01-31       Impact factor: 3.575

8.  Fusogenic activity of SIV (simian immunodeficiency virus) peptides located in the GP32 NH2 terminal domain.

Authors:  I Martin; F Defrise-Quertain; V Mandieau; N M Nielsen; T Saermark; A Burny; R Brasseur; J M Ruysschaert; M Vandenbranden
Journal:  Biochem Biophys Res Commun       Date:  1991-03-29       Impact factor: 3.575

9.  Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses.

Authors:  H Kornfeld; N Riedel; G A Viglianti; V Hirsch; J I Mullins
Journal:  Nature       Date:  1987 Apr 9-15       Impact factor: 49.962

10.  Conformational analysis of lipid-associating proteins in a lipid environment.

Authors:  R Brasseur; H De Loof; J M Ruysschaert; M Rosseneu
Journal:  Biochim Biophys Acta       Date:  1988-08-04
View more
  21 in total

1.  Distribution of hydrophobic residues is crucial for the fusogenic properties of the Ebola virus GP2 fusion peptide.

Authors:  B Adam; L Lins; V Stroobant; A Thomas; R Brasseur
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

2.  Functional analysis of the putative fusion domain of the baculovirus envelope fusion protein F.

Authors:  Marcel Westenberg; Frank Veenman; Els C Roode; Rob W Goldbach; Just M Vlak; Douwe Zuidema
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis.

Authors:  Ngoc-Quynh-Nhu Nguyen; Sebastien P Tabruyn; Laurence Lins; Michelle Lion; Anne M Cornet; Florence Lair; Francoise Rentier-Delrue; Robert Brasseur; Joseph A Martial; Ingrid Struman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-14       Impact factor: 11.205

4.  "De novo" design of peptides with specific lipid-binding properties.

Authors:  L Lins; B Charloteaux; C Heinen; A Thomas; R Brasseur
Journal:  Biophys J       Date:  2005-11-04       Impact factor: 4.033

5.  Mutations in the fusion peptide and heptad repeat regions of the Newcastle disease virus fusion protein block fusion.

Authors:  T Sergel-Germano; C McQuain; T Morrison
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

6.  Common prevalence of alanine and glycine in mobile reactive centre loops of serpins and viral fusion peptides: do prions possess a fusion peptide?

Authors:  I Callebaut; A Tasso; R Brasseur; A Burny; D Portetelle; J P Mornon
Journal:  J Comput Aided Mol Des       Date:  1994-04       Impact factor: 3.686

7.  HIV fusion peptide penetrates, disorders, and softens T-cell membrane mimics.

Authors:  Stephanie Tristram-Nagle; Rob Chan; Edgar Kooijman; Pradeep Uppamoochikkal; Wei Qiang; David P Weliky; John F Nagle
Journal:  J Mol Biol       Date:  2010-07-22       Impact factor: 5.469

8.  Studies on the fusion peptide of a paramyxovirus fusion glycoprotein: roles of conserved residues in cell fusion.

Authors:  C M Horvath; R A Lamb
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

9.  Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines.

Authors:  Z R Israel; P F Edmonson; D H Maul; S P O'Neil; S P Mossman; C Thiriart; L Fabry; O Van Opstal; C Bruck; F Bex
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

10.  Lipid membrane fusion induced by the human immunodeficiency virus type 1 gp41 N-terminal extremity is determined by its orientation in the lipid bilayer.

Authors:  I Martin; H Schaal; A Scheid; J M Ruysschaert
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.